- Home
- STRO vs JGH Comparison
STRO vs JGH Comparison
Compare STRO & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- JGH
- Stock Information
- Founded
- STRO 2003
- JGH 2014
- Country
- STRO United States
- JGH United States
- Employees
- STRO N/A
- JGH N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- JGH Investment Managers
- Sector
- STRO Health Care
- JGH Finance
- Exchange
- STRO Nasdaq
- JGH Nasdaq
- Market Cap
- STRO 172.8M
- JGH 308.3M
- IPO Year
- STRO 2018
- JGH N/A
- Fundamental
- Price
- STRO $1.93
- JGH $12.76
- Analyst Decision
- STRO Strong Buy
- JGH
- Analyst Count
- STRO 7
- JGH 0
- Target Price
- STRO $12.14
- JGH N/A
- AVG Volume (30 Days)
- STRO 1.4M
- JGH 73.9K
- Earning Date
- STRO 11-13-2024
- JGH 01-01-0001
- Dividend Yield
- STRO N/A
- JGH 9.85%
- EPS Growth
- STRO N/A
- JGH N/A
- EPS
- STRO N/A
- JGH N/A
- Revenue
- STRO $160,955,000.00
- JGH N/A
- Revenue This Year
- STRO N/A
- JGH N/A
- Revenue Next Year
- STRO N/A
- JGH N/A
- P/E Ratio
- STRO N/A
- JGH N/A
- Revenue Growth
- STRO 230.90
- JGH N/A
- 52 Week Low
- STRO $1.70
- JGH $10.36
- 52 Week High
- STRO $6.13
- JGH $12.85
- Technical
- Relative Strength Index (RSI)
- STRO 29.88
- JGH 30.57
- Support Level
- STRO $1.70
- JGH $12.65
- Resistance Level
- STRO $3.01
- JGH $13.38
- Average True Range (ATR)
- STRO 0.21
- JGH 0.12
- MACD
- STRO -0.02
- JGH -0.07
- Stochastic Oscillator
- STRO 17.56
- JGH 15.07
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.